Aprogen Pharmaceuticals Inc (003060) — Capital Reinvestment Ratio
Aprogen Pharmaceuticals Inc (003060) has a Capital Reinvestment Ratio of 0.87x as of December 2022, meaning it reinvests 1% of its operating cash flow (₩676.93 Million) in capital expenditures (₩591.03 Million). Check 003060 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aprogen Pharmaceuticals Inc Capital Reinvestment Ratio (2010–2022)
This chart tracks Aprogen Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Aprogen Pharmaceuticals Inc (003060) cash conversion ratio.
Annual Capital Reinvestment Ratio for Aprogen Pharmaceuticals Inc (2010–2022)
Year-by-year Capital Reinvestment Ratio for Aprogen Pharmaceuticals Inc from 2010 to 2022. See Aprogen Pharmaceuticals Inc (003060) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.06x | ₩25.73 Billion | ₩1.55 Billion | ▼ -50.2% |
| 2020 | 0.12x | ₩8.09 Billion | ₩976.29 Million | ▼ -96.0% |
| 2019 | 2.98x | ₩713.73 Million | ₩2.13 Billion | ▲ +292.2% |
| 2018 | 0.76x | ₩1.33 Billion | ₩1.01 Billion | ▼ -87.9% |
| 2016 | 6.27x | ₩449.98 Million | ₩2.82 Billion | ▲ +115.6% |
| 2015 | 2.91x | ₩1.85 Billion | ₩5.37 Billion | ▼ -94.1% |
| 2010 | 49.52x | ₩247.92 Million | ₩12.28 Billion | — |